Gene-editing technique to treat lung cancer is due to be tested in people in August
Chinese scientists are on the verge of being first in the world to inject people with cells modified using the CRISPR–Cas9 gene-editing technique.
A team led by Lu You, an oncologist at Sichuan University’s West China Hospital in Chengdu, plans to start testing such cells in people with lung cancer next month. The clinical trial received ethical approval from the hospital’s review board on July 6.
“It’s an exciting step forward,” says Carl June, a clinical researcher in immunotherapy at the University of Pennsylvania in Philadelphia.
There have been a number of human clinical trials using an alternative gene-editing technique, including one led by June, that have helped patients combat HIV. June is also a scientific adviser on a planned US trial that would also use CRISPR–Cas9-modified cells for the treatment of cancer.
Last month, an advisory panel of the US National Institutes of Health (NIH) approved that project. But the trial also requires a green light from the US Food and Drug Administration (FDA) and a university review board. The US researchers have said they could start their clinical trial by the end of this year.
The Chinese trial will enrol patients who have metastatic non-small cell lung cancer and for whom chemotherapy, radiation therapy and other treatments have failed. “Treatment options are very limited,” says Lu. “This technique is of great promise in bringing benefits to patients, especially the cancer patients whom we treat every day.”
The Latest on: CRISPR
via Google News
The Latest on: CRISPR
- Faster, better, cheaper: the rise of CRISPR in disease detection on February 19, 2019 at 11:27 am
An epidemic of Lassa fever in Nigeria that has killed 69 people this year is on track to be the worst ever recorded anywhere. Now, in the hope of reducing deaths from Lassa in years to come, researche... […]
- CRISPR/Cas9 therapy can suppress aging, enhance health and extend life span in mice on February 19, 2019 at 8:52 am
Researchers have developed a new gene therapy to help decelerate the aging process. The findings highlight a novel CRISPR/Cas9 genome-editing therapy that can suppress the accelerated aging observed i... […]
- MilliporeSigma to Be Awarded First U.S. CRISPR Patent on February 19, 2019 at 7:35 am
MilliporeSigma said today its first CRISPR-related patent will be awarded in the U.S., as a result of the U.S. Patent and Trademark Office issuing a formal Notice of Allowance for MilliporeSigma’s app... […]
- A new CRISPR/Cas9 therapy can suppress aging on February 19, 2019 at 7:30 am
Aging is a leading risk factor for a number of debilitating conditions, including heart disease, cancer and Alzheimer's disease, to name a few. This makes the need for anti-aging therapies all the ... […]
- CRISPR Gene Editing Makes Stem Cells ‘Invisible’ to Immune System on February 19, 2019 at 6:06 am
UC San Francisco scientists have used the CRISPR-Cas9 gene-editing system to create the first pluripotent stem cells that are functionally “invisible” to the immune system, a feat of biological engine... […]
- CRISPR Sleight of Hand Generates Immunologically Invisible Stem Cells on February 19, 2019 at 5:40 am
An international research team has used CRISPR-Cas9 gene editing to render induced pluripotent stem cells (iPSCs) invisible to the immune system, a bioengineering sleight of hand that initial in vivo ... […]
- CRISPR Therapeutics and StrideBio Expand Exclusive Development and Option Agreement on February 19, 2019 at 4:00 am
ZUG, Switzerland and CAMBRIDGE, Mass. and Durham, N.C., Feb 19, 2019 (GLOBE NEWSWIRE via COMTEX) -- ZUG, Switzerland and CAMBRIDGE, Mass. and Durham, N.C., Feb. 19, 2019 (GLOBE NEWSWIRE) -- CRISPR The... […]
- Vaccines don’t work against some viruses. CRISPR might one day fix that on February 19, 2019 at 1:49 am
Two centuries isn’t a bad run for a medical technology. But while vaccination has prevented hundreds of millions of deaths since 1796, when Edward Jenner inoculated a boy with cowpox to prevent smallp... […]
- DMD: Single CRISPR treatment provides long-term benefits in mice on February 18, 2019 at 10:14 am
Researchers have shown that a single systemic treatment using CRISPR genome editing technology can safely and stably correct a genetic disease -- Duchenne muscular dystrophy (DMD) -- for more than a y... […]
- Scientists use CRISPR to make stem cells invisible to immune system on February 18, 2019 at 8:00 am
Scientists at the University of California San Francisco have developed a new method to minimize the likelihood that a person's body will reject stem cells during a transplant. Using the CRISPR gene e... […]
via Bing News